RXO, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-97.6% vs price
Base Case (Median)
-95.4% vs price
Bull Case (75th pct.)
-93.1% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $0.03 | -99.9% | High (40%) |
| EV/EBITDA | $2.14 | -90.9% | Medium (20%) |
Based on 2 out of 8 methods, RXO appears overvalued at the current price of $23.45. The base case fair value of $1.09 implies 95.4% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.